Cumberland Pharmaceuticals Inc. Fair Value of Assets Acquired
Cumberland Pharmaceuticals Inc. (CPIX) reported Fair Value of Assets Acquired of $26.69 thousand for the 3-month period ending 2011-03-31, per its 10-Q filed 2012-05-04.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:FairValueOfAssetsAcquired · last filed 2012-05-04
- Cumberland Pharmaceuticals Inc. fair value of assets acquired for the quarter ending 2011-03-31 was $26.69K.
| Period end | Fair Value of Assets Acquired 3 month |
|---|---|
| 2011-03-31 | $26.69K 10-Q · filed 2012-05-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |